Coronavirus disease 2019 and cardiovascular disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease 2019 (COVID-19) pandemic, is a type of RNA virus that is nonsegmented. Cardiovascular diseases (CVDs) increase the mortality risk of patients. In this review article, we overview the existing evide...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Series: | Tzu Chi Medical Journal |
| Subjects: | |
| Online Access: | http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2023;volume=35;issue=3;spage=213;epage=220;aulast=Song |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850196042747740160 |
|---|---|
| author | Jenn-Yeu Song Jian-You Huang Yi-Chiung Hsu Men-Tzung Lo Chen Lin Ta-Chung Shen Min-Tser Liao Kuo-Cheng Lu |
| author_facet | Jenn-Yeu Song Jian-You Huang Yi-Chiung Hsu Men-Tzung Lo Chen Lin Ta-Chung Shen Min-Tser Liao Kuo-Cheng Lu |
| author_sort | Jenn-Yeu Song |
| collection | DOAJ |
| description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease 2019 (COVID-19) pandemic, is a type of RNA virus that is nonsegmented. Cardiovascular diseases (CVDs) increase the mortality risk of patients. In this review article, we overview the existing evidence regarding the potential mechanisms of myocardial damage in coronavirus disease 2019 (COVID-19) patients. Having a comprehensive knowledge of the cardiovascular damage caused by SARS-CoV-2 and its underlying mechanisms is essential for providing prompt and efficient treatment, ultimately leading to a reduction in mortality rates. Severe COVID-19 causes acute respiratory distress syndrome and shock in patients. In addition, awareness regarding COVID-19 cardiovascular manifestations has increased, including the adverse impact on prognosis with cardiovascular involvement. Angiotensin-converting enzyme 2 receptor may play a role in acute myocardial injury caused by SARS-CoV-2 infection. COVID-19 patients experiencing heart failure may have their condition exacerbated by various contributing factors and mechanisms. Increased oxygen demand, myocarditis, stress cardiomyopathy, elevated pulmonary pressures, and venous thrombosis are potential health issues. The combination of these factors may lead to COVID-19-related cardiogenic shock, resulting in acute systolic heart failure. Extracorporeal membrane oxygenation (ECMO) and left ventricular assist devices (LVADs) are treatment options when inotropic support fails for effective circulatory support. To ensure effective COVID-19-related cardiovascular disease (CVD) surveillance, it is crucial to closely monitor the future host adaptation, viral evolution, and transmissibility of SARS-CoV-2, given the virus's pandemic potential. |
| format | Article |
| id | doaj-art-57eed861027b47fdb96a86c39aee7fad |
| institution | OA Journals |
| issn | 1016-3190 2223-8956 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Tzu Chi Medical Journal |
| spelling | doaj-art-57eed861027b47fdb96a86c39aee7fad2025-08-20T02:13:35ZengWolters Kluwer Medknow PublicationsTzu Chi Medical Journal1016-31902223-89562023-01-0135321322010.4103/tcmj.tcmj_219_22Coronavirus disease 2019 and cardiovascular diseaseJenn-Yeu SongJian-You HuangYi-Chiung HsuMen-Tzung LoChen LinTa-Chung ShenMin-Tser LiaoKuo-Cheng LuSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease 2019 (COVID-19) pandemic, is a type of RNA virus that is nonsegmented. Cardiovascular diseases (CVDs) increase the mortality risk of patients. In this review article, we overview the existing evidence regarding the potential mechanisms of myocardial damage in coronavirus disease 2019 (COVID-19) patients. Having a comprehensive knowledge of the cardiovascular damage caused by SARS-CoV-2 and its underlying mechanisms is essential for providing prompt and efficient treatment, ultimately leading to a reduction in mortality rates. Severe COVID-19 causes acute respiratory distress syndrome and shock in patients. In addition, awareness regarding COVID-19 cardiovascular manifestations has increased, including the adverse impact on prognosis with cardiovascular involvement. Angiotensin-converting enzyme 2 receptor may play a role in acute myocardial injury caused by SARS-CoV-2 infection. COVID-19 patients experiencing heart failure may have their condition exacerbated by various contributing factors and mechanisms. Increased oxygen demand, myocarditis, stress cardiomyopathy, elevated pulmonary pressures, and venous thrombosis are potential health issues. The combination of these factors may lead to COVID-19-related cardiogenic shock, resulting in acute systolic heart failure. Extracorporeal membrane oxygenation (ECMO) and left ventricular assist devices (LVADs) are treatment options when inotropic support fails for effective circulatory support. To ensure effective COVID-19-related cardiovascular disease (CVD) surveillance, it is crucial to closely monitor the future host adaptation, viral evolution, and transmissibility of SARS-CoV-2, given the virus's pandemic potential.http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2023;volume=35;issue=3;spage=213;epage=220;aulast=Songangiotensin-converting enzyme 2 receptorcardiovascular diseasecoronavirus disease 2019 |
| spellingShingle | Jenn-Yeu Song Jian-You Huang Yi-Chiung Hsu Men-Tzung Lo Chen Lin Ta-Chung Shen Min-Tser Liao Kuo-Cheng Lu Coronavirus disease 2019 and cardiovascular disease Tzu Chi Medical Journal angiotensin-converting enzyme 2 receptor cardiovascular disease coronavirus disease 2019 |
| title | Coronavirus disease 2019 and cardiovascular disease |
| title_full | Coronavirus disease 2019 and cardiovascular disease |
| title_fullStr | Coronavirus disease 2019 and cardiovascular disease |
| title_full_unstemmed | Coronavirus disease 2019 and cardiovascular disease |
| title_short | Coronavirus disease 2019 and cardiovascular disease |
| title_sort | coronavirus disease 2019 and cardiovascular disease |
| topic | angiotensin-converting enzyme 2 receptor cardiovascular disease coronavirus disease 2019 |
| url | http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2023;volume=35;issue=3;spage=213;epage=220;aulast=Song |
| work_keys_str_mv | AT jennyeusong coronavirusdisease2019andcardiovasculardisease AT jianyouhuang coronavirusdisease2019andcardiovasculardisease AT yichiunghsu coronavirusdisease2019andcardiovasculardisease AT mentzunglo coronavirusdisease2019andcardiovasculardisease AT chenlin coronavirusdisease2019andcardiovasculardisease AT tachungshen coronavirusdisease2019andcardiovasculardisease AT mintserliao coronavirusdisease2019andcardiovasculardisease AT kuochenglu coronavirusdisease2019andcardiovasculardisease |